Clinical trial
Randomized Controlled Trial Comparing Cellular Matrix Combination of Platelet Rich Plasma With Hyaluronic Acid (CM-PRP-HA) Versus Hyaluronic Acid in Knee Osteoarthritis
NCT05076526 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial Comparing Cellular Matrix Combination of Platelet Rich Plasma With Hyaluronic Acid (CM-PRP-HA) Versus Hyaluronic Acid in Knee Osteoarthritis
- Lead sponsor
- Singapore General Hospital
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- November 30, 2021
- Completion date
- November 30, 2022
- Enrollment
- 132 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.